Finland· FI-REL-REL64201
Fibryga
A fibrinogen, human product containing human fibrinogen, registered in Finland by Octapharma AB. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Fibrinogen, human is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BB01 (fibrinogen, human), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Fibrinogen, human · ATC B02BB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of fibrinogen, human costs, country by country.
Normalised to the WHO defined daily dose (5 g), the median price runs from $2.30 in Czechia to $2694.05 in Switzerland — a ×1171 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fibrinogen, human · price per daily dose (5 g)
USD · FX 28 Sept 2026
- CH Switzerland$2694.05
- CZ Czechia$2.30
The record
At a glance
Fimea (Finland)- Active substance
- Human fibrinogen
- Manufacturer
- Octapharma AB
- Country
- Finland (FI)
- ATC code
- B02BB01
- ATC class
- Fibrinogen, human
- Defined daily dose
- 5 g, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for fibrinogen, human.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fibrinogen, human · interactions on record
2 records
- 2 severe
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fibrinogen, human in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainFIBRYGA 2 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSIONOctapharma S.A.
- PolandFibrygaOctapharma (IP) SPRL
- SwedenFibryga 2 g Pulver och vätska till injektions-/infusionsvätska, lösningOctapharma AB
- IrelandFIBRYGA 2 g powder and solvent for solution for injection/infusionOctapharma (IP)
- SwitzerlandHaemocomplettan P
- BelgiumRiastap 2 gCSL Behring
- United KingdomARTISS solution for sealant 10ml pre-filled syringesBaxter Healthcare Ltd
- NetherlandsFibclot 1,5 g, poeder en oplosmiddel voor oplossing voor injectie/infusieLaboratoire Francais Du Fractionnement Et Des Biotechnologies
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Fibclot, Fibryga
- Belgium · Fibclot, Fibryga
- Bulgaria · Fibryga, Хемокомплетан P
- Cyprus · Fibryga, Riastap
- Czechia · Fibryga, Haemocomplettan P
- Germany · Fibclot, Fibryga
- Denmark · Fibclot, Fibryga
- Estonia · Fibryga
- Spain · Fibclot, Fibryga
- France · Clottafact, Fibryga
- United Kingdom (Northern Ireland) · Fibclot, Fibryga
- Greece · Fibclot, Riastap
- Croatia · Fibryga
- Hungary · Fibclot, Fibryga
- Ireland · Fibryga, Riastap
- Iceland · Fibryga, Riastap
- Italy · Fibriclotte, Fibryga
- Lithuania · Fibryga
- Luxembourg · Fibclot, Fibryga
- Latvia · Fibryga
- Malta · Fibryga, Riastap
- Netherlands · Fibclot, Fibryga
- Norway · Fibclot, Fibryga
- Poland · Fibryga, Riastap
- Portugal · Fibryga, Haemocomplettan
- Romania · Fibryga, Haemocomplettan P
- Sweden · Fibclot, Fibryga
- Slovenia · Fibrema, Prufibry
- Slovakia · Fibryga, Riastap
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a3ec9b8c-0597-45d8-ba30-683393e1493b GET /v1/drugs/a3ec9b8c-0597-45d8-ba30-683393e1493b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "5",
"form": "injektio-/infuusiokuiva-aine ja liuotin, liuosta varten",
"route": "Laskimoon",
"ddd_unit": "g",
"strength": "2 g",
"atc_label": "fibrinogeeni, ihmisen",
"ma_number": "45140",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL64201",
"authorised_at": "2026-06-01"
}See everything about fibrinogen, human.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.